Development And Application Of New Microchip CE DNA Assays For Point-Of-Care Testing In Routine Cancer Diagnosis And Therapy

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F26475821%3A_____%2F10%3A%230000098" target="_blank" >RIV/26475821:_____/10:#0000098 - isvavai.cz</a>

Result on the web

—

DOI - Digital Object Identifier

—

Result language

angličtina

Original language name

Development And Application Of New Microchip CE DNA Assays For Point-Of-Care Testing In Routine Cancer Diagnosis And Therapy

Original language description

Over the past several years, the flagship application for DNA separation by capillary electrophoresis, the DNA sequencing, has slowly been conquered by next-generation approaches (next-gen). These technologies, capable of analyzing events at a single-molecule level, are now being used for a wide variety of applications from the discovery of de novo sequences, massive mutation detection and screening as well as gene expression by sequencing counting. There is no doubt that the next-gen techniques have already greatly accelerated many areas of genomic research.

Czech name

—

Czech description

—

Type

A - Audiovisual production

CEP classification

FD - Oncology and haematology

OECD FORD branch

—

Project

<a href="/en/project/FI-IM3%2F215" target="_blank" >FI-IM3/215: Research, development and implementation of technology for manufacturing of DNA diagnostic kits.</a><br>

Continuities

P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)<br>O - Projekt operacniho programu

Publication year

2010

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

ISBN

—

Place of publication

—

Publisher/client name

—

Version

—

Carrier ID

—